Q: Hi team,

Do you find anything worth buying now for growth, in these stars of 2025 ?

Resolute Holdings rhld-n Terns Pharma tern-q Celcuity celc-q Nanobiotix nbtx-q Cidara Therapeutics cdtx-q Palvella Therapeutics pvla-q Almonty Industries alm-q Hycroft Mining hymc-q Abivax abvx-q Regencell Bio rgc-Q

In which order would you buy ?

Gratefully,

Jacques IDS

Q: I’m looking into Almonty and trying to separate substance from narrative.

Tungsten is often framed as a U.S. critical mineral and the West is clearly dependent on China, but I’m wondering how much that actually translates into shareholder value. Sangdong in South Korea only restarted production in 2025, but it did operate historically and shut down mainly due to pricing and Chinese oversupply rather than geology.

Management also recently hired a former U.S. general into a senior operating role, which could signal an attempt to align with defense or strategic supply chains, though it’s unclear how tangible that is in practice.

What % of portfolio allocation would you recommend? And how do you view the future growth of this company?

Q: Almonty seems to be gaining traction with the imminent mine opening in S Korea. It has purchased another mine in the US and is moving its head office to the states. With the price for tungsten doubling in the last year and the demand growing, this appears to be a small cap with lots of upside. Thoughts?